Maki Hitomi, Imai Hisanori, Yamada Hiroko, Tetsumoto Akira, Hayashida Mayuka, Otsuka Keiko, Miki Akiko, Nakamura Makoto
Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.
Retin Cases Brief Rep. 2023 Mar 1;17(2):101-104. doi: 10.1097/ICB.0000000000001117.
To report the case of a patient with cystoid macular edema secondary to idiopathic macular telangiectasia (MacTel) Type 1, which was successfully treated by cystotomy and en bloc removal of the fibrinogen-rich component of the cystoid lesion.
An 80-year-old man was referred to our department because of a visual defect in his right eye. His best-corrected decimal visual acuity was 0.7 (Snellen equivalent, 20/30). A fundus examination revealed clustered temporal juxafoveal microaneurysms and foveal cystoid macular edema. The patient refused to undergo conventional treatments, including direct retinal photocoagulation for microaneurysms, intravitreal anti-vascular endothelial growth factor injection, and intravitreal triamcinolone injection. However, he provided consent to undergo cystotomy and en bloc removal of the fibrinogen-rich component of the cystoid lesion.
His best-corrected decimal visual acuity was 0.2 (Snellen equivalent, 20/100) just before the surgery. A 27-gauge vitrectomy with internal limiting membrane peeling was performed. Cystotomy was performed during the surgery, and the fibrinogen clot visible in the cystoid cavity was also removed. Cystoid macular edema rapidly disappeared after the surgery. Three years postoperatively, the patient had best-corrected decimal visual acuity of 0.5 (Snellen equivalent, 20/40) at the last medical examination, and the cystoid macular edema had not recurred.
Cystotomy and en bloc removal of the fibrinogen-rich component of the cystoid lesion could be valid treatment options for cystoid macular edema secondary to MacTel Type 1.
报告1例继发于特发性黄斑毛细血管扩张症(MacTel)1型的黄斑囊样水肿患者,通过囊切开术及整块切除囊样病变中富含纤维蛋白原的成分后获得成功治疗的病例。
一名80岁男性因右眼视力缺陷转诊至我科。其最佳矫正小数视力为0.7(Snellen等效视力,20/30)。眼底检查发现颞侧近黄斑中心凹处有簇状微动脉瘤及黄斑囊样水肿。患者拒绝接受包括针对微动脉瘤的直接视网膜光凝、玻璃体内抗血管内皮生长因子注射及玻璃体内曲安奈德注射等传统治疗。然而,他同意接受囊切开术及整块切除囊样病变中富含纤维蛋白原的成分。
术前其最佳矫正小数视力为0.2(Snellen等效视力,20/100)。行27G玻璃体切除术并剥除内界膜。术中进行囊切开术,并将囊样腔内可见的纤维蛋白凝块一并切除。术后黄斑囊样水肿迅速消失。术后三年,在最后一次医学检查时,患者最佳矫正小数视力为0.5(Snellen等效视力,20/40),黄斑囊样水肿未复发。
囊切开术及整块切除囊样病变中富含纤维蛋白原的成分可能是治疗继发于MacTel 1型的黄斑囊样水肿的有效选择。